Cargando…

Development of a porcine acellular bladder matrix for tissue-engineered bladder reconstruction

PURPOSE: Enterocystoplasty is adopted for patients requiring bladder augmentation, but significant long-term complications highlight need for alternatives. We established a protocol for creating a natural-derived bladder extracellular matrix (BEM) for developing tissue-engineered bladder, and invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Garriboli, Massimo, Deguchi, Koichi, Totonelli, Giorgia, Georgiades, Fanourios, Urbani, Luca, Ghionzoli, Marco, Burns, Alan J., Sebire, Neil J., Turmaine, Mark, Eaton, Simon, De Coppi, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983501/
https://www.ncbi.nlm.nih.gov/pubmed/35316841
http://dx.doi.org/10.1007/s00383-022-05094-2
_version_ 1784681986256797696
author Garriboli, Massimo
Deguchi, Koichi
Totonelli, Giorgia
Georgiades, Fanourios
Urbani, Luca
Ghionzoli, Marco
Burns, Alan J.
Sebire, Neil J.
Turmaine, Mark
Eaton, Simon
De Coppi, Paolo
author_facet Garriboli, Massimo
Deguchi, Koichi
Totonelli, Giorgia
Georgiades, Fanourios
Urbani, Luca
Ghionzoli, Marco
Burns, Alan J.
Sebire, Neil J.
Turmaine, Mark
Eaton, Simon
De Coppi, Paolo
author_sort Garriboli, Massimo
collection PubMed
description PURPOSE: Enterocystoplasty is adopted for patients requiring bladder augmentation, but significant long-term complications highlight need for alternatives. We established a protocol for creating a natural-derived bladder extracellular matrix (BEM) for developing tissue-engineered bladder, and investigated its structural and functional characteristics. METHODS: Porcine bladders were de-cellularised with a dynamic detergent–enzymatic treatment using peristaltic infusion. Samples and fresh controls were evaluated using histological staining, ultrastructure (electron microscopy), collagen, glycosaminoglycans and DNA quantification and biomechanical testing. Compliance and angiogenic properties (Chicken chorioallantoic membrane [CAM] assay) were evaluated. T test compared stiffness and glycosaminoglycans, collagen and DNA quantity. p value of < 0.05 was regarded as significant. RESULTS: Histological evaluation demonstrated absence of cells with preservation of tissue matrix architecture (collagen and elastin). DNA was 0.01 μg/mg, significantly reduced compared to fresh tissue 0.13 μg/mg (p < 0.01). BEM had increased tensile strength (0.259 ± 0.022 vs 0.116 ± 0.006, respectively, p < 0.0001) and stiffness (0.00075 ± 0.00016 vs 0.00726 ± 0.00216, p = 0.011). CAM assay showed significantly increased number of convergent allantoic vessels after 6 days compared to day 1 (p < 0.01). Urodynamic studies showed that BEM maintains or increases capacity and compliance. CONCLUSION: Dynamic detergent–enzymatic treatment produces a BEM which retains structural characteristics, increases strength and stiffness and is more compliant than native tissue. Furthermore, BEM shows angiogenic potential. These data suggest the use of BEM for development of tissue-engineered bladder for patients requiring bladder augmentation.
format Online
Article
Text
id pubmed-8983501
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-89835012022-04-22 Development of a porcine acellular bladder matrix for tissue-engineered bladder reconstruction Garriboli, Massimo Deguchi, Koichi Totonelli, Giorgia Georgiades, Fanourios Urbani, Luca Ghionzoli, Marco Burns, Alan J. Sebire, Neil J. Turmaine, Mark Eaton, Simon De Coppi, Paolo Pediatr Surg Int Original Article PURPOSE: Enterocystoplasty is adopted for patients requiring bladder augmentation, but significant long-term complications highlight need for alternatives. We established a protocol for creating a natural-derived bladder extracellular matrix (BEM) for developing tissue-engineered bladder, and investigated its structural and functional characteristics. METHODS: Porcine bladders were de-cellularised with a dynamic detergent–enzymatic treatment using peristaltic infusion. Samples and fresh controls were evaluated using histological staining, ultrastructure (electron microscopy), collagen, glycosaminoglycans and DNA quantification and biomechanical testing. Compliance and angiogenic properties (Chicken chorioallantoic membrane [CAM] assay) were evaluated. T test compared stiffness and glycosaminoglycans, collagen and DNA quantity. p value of < 0.05 was regarded as significant. RESULTS: Histological evaluation demonstrated absence of cells with preservation of tissue matrix architecture (collagen and elastin). DNA was 0.01 μg/mg, significantly reduced compared to fresh tissue 0.13 μg/mg (p < 0.01). BEM had increased tensile strength (0.259 ± 0.022 vs 0.116 ± 0.006, respectively, p < 0.0001) and stiffness (0.00075 ± 0.00016 vs 0.00726 ± 0.00216, p = 0.011). CAM assay showed significantly increased number of convergent allantoic vessels after 6 days compared to day 1 (p < 0.01). Urodynamic studies showed that BEM maintains or increases capacity and compliance. CONCLUSION: Dynamic detergent–enzymatic treatment produces a BEM which retains structural characteristics, increases strength and stiffness and is more compliant than native tissue. Furthermore, BEM shows angiogenic potential. These data suggest the use of BEM for development of tissue-engineered bladder for patients requiring bladder augmentation. Springer Berlin Heidelberg 2022-03-22 2022 /pmc/articles/PMC8983501/ /pubmed/35316841 http://dx.doi.org/10.1007/s00383-022-05094-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Garriboli, Massimo
Deguchi, Koichi
Totonelli, Giorgia
Georgiades, Fanourios
Urbani, Luca
Ghionzoli, Marco
Burns, Alan J.
Sebire, Neil J.
Turmaine, Mark
Eaton, Simon
De Coppi, Paolo
Development of a porcine acellular bladder matrix for tissue-engineered bladder reconstruction
title Development of a porcine acellular bladder matrix for tissue-engineered bladder reconstruction
title_full Development of a porcine acellular bladder matrix for tissue-engineered bladder reconstruction
title_fullStr Development of a porcine acellular bladder matrix for tissue-engineered bladder reconstruction
title_full_unstemmed Development of a porcine acellular bladder matrix for tissue-engineered bladder reconstruction
title_short Development of a porcine acellular bladder matrix for tissue-engineered bladder reconstruction
title_sort development of a porcine acellular bladder matrix for tissue-engineered bladder reconstruction
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983501/
https://www.ncbi.nlm.nih.gov/pubmed/35316841
http://dx.doi.org/10.1007/s00383-022-05094-2
work_keys_str_mv AT garribolimassimo developmentofaporcineacellularbladdermatrixfortissueengineeredbladderreconstruction
AT deguchikoichi developmentofaporcineacellularbladdermatrixfortissueengineeredbladderreconstruction
AT totonelligiorgia developmentofaporcineacellularbladdermatrixfortissueengineeredbladderreconstruction
AT georgiadesfanourios developmentofaporcineacellularbladdermatrixfortissueengineeredbladderreconstruction
AT urbaniluca developmentofaporcineacellularbladdermatrixfortissueengineeredbladderreconstruction
AT ghionzolimarco developmentofaporcineacellularbladdermatrixfortissueengineeredbladderreconstruction
AT burnsalanj developmentofaporcineacellularbladdermatrixfortissueengineeredbladderreconstruction
AT sebireneilj developmentofaporcineacellularbladdermatrixfortissueengineeredbladderreconstruction
AT turmainemark developmentofaporcineacellularbladdermatrixfortissueengineeredbladderreconstruction
AT eatonsimon developmentofaporcineacellularbladdermatrixfortissueengineeredbladderreconstruction
AT decoppipaolo developmentofaporcineacellularbladdermatrixfortissueengineeredbladderreconstruction